Antiviral Efficacy of Pralatrexate against SARS-CoV-2
1Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul 02841,
2Biosafety Center, Korea University College of Medicine, Seoul 02841, Republic of Korea
(Park MS), email@example.com
Tel: +82-2-2286-1312 (Park MS), +82-2-2286-1313 (Kim JI)
Fax: +82-2-923-3645 (Park MS), +82-2-923-3645 (Kim JI)†
The first two authors contributed equally to this work.
Received: February 8, 2021; Revised: February 26, 2021; Accepted: March 1, 2021; Published online: March 17, 2021.
© The Korean Society of Applied Pharmacology. All rights reserved.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/
) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.